Kohima News Paper

By 2026, AI in Pharmaceutical Market Size Grow at 47% CAGR, Will Reach USD 8150 Million by 2026: Facts & Factors

 Breaking News
  • No posts were found

By 2026, AI in Pharmaceutical Market Size Grow at 47% CAGR, Will Reach USD 8150 Million by 2026: Facts & Factors

June 17
19:30 2021
By 2026, AI in Pharmaceutical Market Size Grow at 47% CAGR, Will Reach USD 8150 Million by 2026: Facts & Factors
According to Facts and Factors study concludes that the global AI in Pharmaceutical Market is expected to grow at a CAGR of 47% between 2016 and 2021. The market revenue of US $550 Million in 2019 is expected to grow up to US $8150 Million by 2026. The main drivers for the growth of the market are reduction in the cost and time of drug discovery is the major factor responsible for the growth of AI in Pharmaceutical.

According to the Facts and Factors study concludes that the global AI in Pharmaceutical Market is expected to grow at a CAGR of 47% between 2020 and 2026. The market revenue of US $550 Million in 2019 is expected to grow up to the US $8150 Million by 2026. The main drivers for the growth of the market are reduction in the cost and time of drug discovery is the major factor responsible for the growth of AI in Pharmaceutical.

Global AI for Pharmaceutical Market: Overview              

AI in pharmaceutical applications refers to the system of automated and interconnected technologies that are able to function autonomously and requires very minute or no human interventions. AI analyses the colossal amount of data by utilizing techniques like deep learning, machine learning, adaptive learning, natural language processing, and computer vision. Both the biopharmaceutical and pharmaceutical companies are leveraging AI for various applications including drug development, drug discovery, and drug commercialization.

AI and machine learning have encompassed all the prominent sectors of the industries. AI refers to the system of technology in which intelligent sensors collect a plethora of information and analyzes this data and activates a response in the shortest possible time. AI in pharmaceutical plays an important role in predicting the success rate of experiment based on various biological and non-biological factors

Request Your Free Sample Report of Global AI in Pharmaceutical Market @ https://www.fnfresearch.com/sample/ai-for-pharmaceutical-market

(The free sample of this report is readily available on request).

Our Free Sample Report Includes:

  • 2020 Updated Report Introduction, Overview, and In-depth industry analysis
  • COVID-19 Pandemic Outbreak Impact Analysis Included
  • 195+ Pages Research Report (Inclusion of Updated Research)
  • Provide Chapter-wise guidance on Request
  • 2020 Updated Regional Analysis with Graphical Representation of Size, Share & Trends
  • Includes Updated List of table & figures
  • Updated Report Includes Top Market Players with their Business Strategy, Sales Volume, and Revenue Analysis
  • Facts and Factors research methodology

 

(Note: The sample of this report is updated with COVID-19 impact analysis before delivery)

Industry Major Market Players

  • Pfizer
  • Janssen Pharmaceutical
  • Sanofi
  • Novartis
  • Bayer
  • Takeda
  • Roche
  • Merck
  • Glaxo SmithKline
  • Eli Lilly
  • Astra Zeneca
  • Allergan 

 

To know an additional revised list of 2020-2021 top market players, request a sample report: https://www.fnfresearch.com/sample/ai-for-pharmaceutical-market

Reduction in the cost and time of drug discovery is the major factor responsible for the growth of AI in Pharmaceutical

AI has the potential to accelerate the new discovery and also increase productivity reducing the cost of operation and time to market. It assists in screening the drug compound and based on that predicting the success rate of the experiment thus reducing the chances of errors and increasing the success rate of research and development activities. The plethora of data is analyzed and acted in fractions of seconds this increases the efficiency of the enterprise. One of the major time-consuming processes in drug discovery in clinical trials. Recruitment of patients for clinical trials is a time-consuming task, AI-assisted technology can scrutinize patients in nanoseconds and identify the right candidates based on disease history and other additional attributes which effectively shortens the process of introducing drugs in the market.

Request Customized Copy of Report @ https://www.fnfresearch.com/customization/ai-for-pharmaceutical-market

(We customize your report according to your research need. Ask our sales team for report customization.)

North America region is projected to Dominate Global AI in Pharmaceutical Market Growth

Geographically, North America is dominating the global market for AI for pharmaceutical. The regional market share is mainly driven by U.S. and Canada; massive investments in AI technologies and a large number of cross-industry strategic collaborations majorly fuel the growth of the AI for pharmaceutical market. Additionally, the presence of major market contributors such as Google, IBM, NVIDIA, Microsoft, and Intel, are headquartered in this region which is aiding the market to grow. However, Asia-Pacific is expected to register the highest CAGR growth over the projected period, owing to the rise in adoption of advanced AI technologies and the focus of major players on expanding their market presence in emerging countries of Asia. Thereby, certain factors are responsible for the large share and high growth rate of this market.

Browse detail report with in-depth TOC @ https://www.fnfresearch.com/ai-for-pharmaceutical-market

The global AI in Pharmaceutical market is segmented as follows:

By Technology

  • Context-Aware Processing
  • Natural Language Processing
  • Machine learning
  • Deep Learning

 

By Offering:

  • Software
  •  Service

 

By Application

  • Drug Discovery
  • Research & Development
  • Diagnosis
  • Epidemic Prediction
  • Disease Prevention
  • Remote Monitoring
  • Manufacturing
  •  Marketing

 

About Us:
Facts & Factors is a leading market research organization offering industry expertise and scrupulous consulting services to clients for their business development. The reports and services offered by Facts and Factors are used by prestigious academic institutions, start-ups, and companies globally to measure and understand the changing international and regional business backgrounds. Our client’s/customer’s conviction on our solutions and services has pushed us in delivering always the best. Our advanced research solutions have helped them in appropriate decision-making and guidance for strategies to expand their business.

Contact Us:
Facts & Factors
Global Headquarters
A 2108, Sargam,
Nanded City,
Sinhagad Road,
Pune 411041, India
Tel: +91 96043 17127
USA: 1 (347) 690-0211
Email: [email protected]
Web: https://www.fnfresearch.com

Media Contact
Company Name: Facts & Factors (FnF Research)
Contact Person: Facts & Factors
Email: Send Email
Phone: +1 (347) 690-0211
Address:A 2108, Sargam, Nanded City, Sinhagad Road
City: Pune
Country: India
Website: https://www.fnfresearch.com/ai-for-pharmaceutical-market